Cargando…

Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience

BACKGROUND: Children with congenital adrenal hyperplasia (CAH) because of 21 hydroxylase deficiency (21OHD) are at risk for early or precocious puberty and a short adult height compared to population means and midparental height. The effect of histrelin in suppressing puberty and improving growth in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swendiman, Robert A, Coons, Barbara E, Alter, Craig A, Bamba, Vaneeta, Nance, Michael L, Vogiatzi, Maria G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035208/ https://www.ncbi.nlm.nih.gov/pubmed/32104750 http://dx.doi.org/10.1210/jendso/bvz004

Ejemplares similares

Extended Use of Histrelin Implant in Pediatric Patients
por: Pine-Twaddell, Elyse, et al.
Publicado: (2023)

SAT-298 A Case of a Forgotten Histrelin Acetate Implant: Can Histrelin Acetate Implants Be Used for More Than a Year?
por: KV Krishnaraj, Balasundari, et al.
Publicado: (2019)

Results of a Second Year of Therapy with the 12-Month Histrelin Implant for the Treatment of Central Precocious Puberty
por: Rahhal, Samar, et al.
Publicado: (2009)

Crinecerfont, a CRF(1) Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia
por: Newfield, Ron S, et al.
Publicado: (2023)

Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
por: Lin-Su, Karen, et al.
Publicado: (2015)

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
por: Auchus, Richard J, et al.
Publicado: (2021)

Growth characteristics in children with congenital adrenal hyperplasia
por: Alzanbagi, Mashael A., et al.
Publicado: (2018)

Growth and Reproductive Outcomes in Congenital Adrenal Hyperplasia
por: Nebesio, Todd D., et al.
Publicado: (2010)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Normal Intelligence in Female and Male Patients with Congenital Adrenal Hyperplasia
por: Berenbaum, Sheri A., et al.
Publicado: (2010)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)

Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty
por: Villalta, Douglas, et al.
Publicado: (2022)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia
por: Falhammar, Henrik, et al.
Publicado: (2012)

Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis
por: Schoelwer, Melissa J., et al.
Publicado: (2017)

Comment on: Growth characteristics in children with congenital adrenal hyperplasia
por: Al-Mendalawi, Mahmood D.
Publicado: (2018)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

Congenital lipoid adrenal hyperplasia
por: Kim, Chan Jong
Publicado: (2014)

Giant Bilateral Adrenal Myelolipoma with Congenital Adrenal Hyperplasia
por: Al-Bahri, S., et al.
Publicado: (2014)

Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia
por: Claahsen-van der Grinten, H. L., et al.
Publicado: (2009)

Editorial: Management of Females with Congenital Adrenal Hyperplasia
por: González, Ricardo, et al.
Publicado: (2017)

Sexual Well-Being in Adult Male Patients with Congenital Adrenal Hyperplasia
por: Dudzińska, Bogna, et al.
Publicado: (2014)

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
por: Han, Thang S, et al.
Publicado: (2013)

Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia
por: Ali, Salma R, et al.
Publicado: (2020)

Novel treatments for congenital adrenal hyperplasia
por: Schröder, Mariska A. M., et al.
Publicado: (2022)

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021)

Effectiveness of diabetes and congenital adrenal hyperplasia meeting clubs
por: Huynh, Quynh TV, et al.
Publicado: (2013)

Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
por: Flint, Jennifer L., et al.
Publicado: (2013)

Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
por: Carsote, Mara, et al.
Publicado: (2023)

Dexamethasone Therapy of Congenital Adrenal Hyperplasia and the Myth of the “Growth Toxic” Glucocorticoid
por: Rivkees, Scott A.
Publicado: (2010)

Testicular adrenal rest tumors in children with congenital adrenal hyperplasia
por: Al-Ghamdi, Waad M., et al.
Publicado: (2021)

Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy
por: Neely, E Kirk, et al.
Publicado: (2013)

Management of the Adult with Congenital Adrenal Hyperplasia
por: Auchus, Richard J.
Publicado: (2010)

Congenital adrenal hyperplasia: Treatment and outcomes
por: Kamoun, Mahdi, et al.
Publicado: (2013)

Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
por: Cuhaci, Neslihan, et al.
Publicado: (2015)

Assisted Reproduction in Congenital Adrenal Hyperplasia
por: Chatziaggelou, Anastasios, et al.
Publicado: (2019)

Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies
por: Sarafoglou, Kyriakie, et al.
Publicado: (2021)

Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia
por: Jones, Christopher M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4fm2o9gv9s4jh7aatuc64a6g1j